摘要
目的:就肾康注射液联合用药在肾小球肾炎合并急性间质性肾炎治疗中的应用疗效进行对比观察。方法:参与本次研究的80例肾小球肾炎合并急性间质性肾炎患者均为于2016年3月至2017年1月期间在平煤神马医疗集团总医院进行治疗的患者,将所有患者随机分为观察组与对照组,其中,给予对照组患者常规治疗,观察组患者则采用肾康注射液联合用药治疗。对比两组患者的整体治疗效果、并发症发生率以及肾功能各项指标。结果:观察组的整体治疗效果、不良反应发生率比对照组优(P<0.05),且观察组的24h尿蛋白定量、尿素氮及血肌酐优于对照组,有统计学差异存在(P<0.05)。结论:对肾小球肾炎合并急性间质性肾炎患者采用肾康注射液联合用药进行治疗,可有效改善患者的肾功能各项指标,从而提高了患者的临床效果,并能有效降低并发症的发生几率。
Objective: To compare the efficacy of combined Shen Kang injection in the treatment of glomerulonephritis complicated with acute interstitial nephritis. Methods: 80 cases of glomerulonephritis in this study associated with acute interstitial nephritis patients were undergoing treatment in Henan Pingmei Shenma Medical Group General Hospital. The time is from March 2016 to January 2017 were randomly divided into observation group and control group. The control group was given conventional treatment, the observation group were treated with Shenkang injection combined treatment. The overall treatment effect, complication rate and the indexes of renal function were compared between the two groups. Results: The overall treatment effect and adverse reaction rate of the observation group were better than that of the control group(P<0.05), and the observation group of 24 h urinary protein quantitative, urea nitrogen and blood creatinine were better than the control group, there was a statistical difference(P<0.05). Conclusion: Acute interstitial nephritis treated by Shenkang injection combined with medication for treatment of glomerulonephritis with renal function indicators of patients can be effectively improved, so as to improve the clinical effect of patients, and can effectively reduce the incidence of complications.
出处
《药品评价》
CAS
2018年第1期38-41,共4页
Drug Evaluation
关键词
肾康注射液
联合用药
肾小球肾炎
急性间质性肾炎
Shen Kang Injection
Combination Therapy
Glomerulonephritis
Acute Interstitial Nephriti
